Related Experiment Video
Updated: Oct 10, 2026

An In Vitro Batch-culture Model to Estimate the Effects of Interventional Regimens on Human Fecal Microbiota
Published on: July 31, 2019
[Gut microbiota-mediated FGF metabolic axis in the pathogenesis, prevention and treatment of various diseases]
Xianxi Ye1, Zhuofan Lu2, Weiru Zhang2
1School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou 325035, China. yxx1752143876@163.com.
Abstract:
The gut microbiota is pivotal in regulating host metabolic homeostasis and is closely associated with the onset, progression, prevention, and treatment of various diseases. Endocrine fibroblast growth factors (FGFs) serve as key signaling molecules through which the gut microbiota influences host metabolic health. Via microbial metabolites, the gut microbiota regulates signaling axes such as FXR-FGF15/19, PPARα-FGF21, and VDR-FGF23, thereby participating in host glucose and lipid metabolism, mineral homeostasis, and inflammatory responses. Gut microbiota-mediated FGF metabolic axes play critical roles in the development and progression of obesity, diabetes, liver disease, gastrointestinal disorders, kidney disease, and cardiovascular disease. Targeting the gut microbiota and FGF metabolic axes through probiotics, prebiotics, postbiotics, and microbiota-derived metabolites may therefore offer promising strategies for the prevention and treatment of these diseases. This review summarizes the mechanistic links between the gut microbiota and FGF metabolic axes, discusses their roles in disease development and progression, and highlights the potential of these mechanisms for developing preventive and therapeutic strategies.
Related Concept Videos
Functions of the Gut Microbiota
Gut-Brain Axis
Dysbiosis of the Gut Microbiota
Microbiota Modulation by Antibiotics
The Oral Microbiota
Probiotics

